Degradation of Human IgA by Entamoeba histolytica

To determine whether the virulent enteric pathogen Entamoeba histolytica degrades human IgA molecules, serum and secretory IgA was exposed to viable axenic trophozoites (strain HM1:IMSS), a parasite sonicate, and medium conditioned by incubation with live trophozoites. IgA was completely degraded un...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infectious diseases 1993-11, Vol.168 (5), p.1319-1322
Hauptverfasser: Kelsall, Brian L., Ravdin, Jonathan I.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1322
container_issue 5
container_start_page 1319
container_title The Journal of infectious diseases
container_volume 168
creator Kelsall, Brian L.
Ravdin, Jonathan I.
description To determine whether the virulent enteric pathogen Entamoeba histolytica degrades human IgA molecules, serum and secretory IgA was exposed to viable axenic trophozoites (strain HM1:IMSS), a parasite sonicate, and medium conditioned by incubation with live trophozoites. IgA was completely degraded under all conditions, proteinase activity was maximal at a neutral pH, and there was a four- to eightfold enrichment of amebic IgA proteolytic activity in a soluble fraction of amebic sonicate. Degradation of serum IgA by amebic sonicate was completely inhibited by the cysteine proteinase inhibitors trans-epoxysuccinyl-l-Ieucylamino(4-guanidino)butane (E-64, 100 µ,M) and benzyloxycarbonyl-phenyl-alanyl-alanyl-fluoromethyl ketone (Z-Phe-AlaCH2F, 12.5 µM). Secretion of degradative activity, the optimal pH, and the inhibition by E-64 and Z-Phe-Ala-CH2F indicates that cysteine proteinase activity is predominately responsible for the degradation of human IgA by E. histolytica.
doi_str_mv 10.1093/infdis/168.5.1319
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_76053023</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30113659</jstor_id><sourcerecordid>30113659</sourcerecordid><originalsourceid>FETCH-LOGICAL-c482t-e34d52eb9424cf0866556201933a323dbfb5cd82e892b00c10d625655956374e3</originalsourceid><addsrcrecordid>eNqFkDtPwzAUhS0EKuXxAxiQMiC2tNe-sZ2MqBRagcRSVMRiOY5TAnmAnUr035OopYxMd_jOOVf6CLmgMKKQ4Lio86zwYyriER9RpMkBGVKOMhSC4iEZAjAW0jhJjsmJ9-8AEKGQAzKIGYtRsiGht3bldKbboqmDJg9m60rXwXx1E6SbYFq3umpsqoO3wrdNuWkLo8_IUa5Lb89395Q8300Xk1n4-HQ_n9w8hiaKWRtajDLObJpELDI5xEJwLhjQBFEjwyzNU26ymNk4YSmAoZAJxrtQwgXKyOIpud7ufrrma219q6rCG1uWurbN2ispgCMw_DfY2WGcyz5It0HjGu-dzdWnKyrtNoqC6n2qrc--objqfXady934Oq1stm_sBHb8ase1N7rMna5Nt_Abi0ACA_ibee88uj1GoBQF79-EW955tt97rt2HEhIlV7OXVzVbLieSPixUhD--mJSz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16825573</pqid></control><display><type>article</type><title>Degradation of Human IgA by Entamoeba histolytica</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><creator>Kelsall, Brian L. ; Ravdin, Jonathan I.</creator><creatorcontrib>Kelsall, Brian L. ; Ravdin, Jonathan I.</creatorcontrib><description>To determine whether the virulent enteric pathogen Entamoeba histolytica degrades human IgA molecules, serum and secretory IgA was exposed to viable axenic trophozoites (strain HM1:IMSS), a parasite sonicate, and medium conditioned by incubation with live trophozoites. IgA was completely degraded under all conditions, proteinase activity was maximal at a neutral pH, and there was a four- to eightfold enrichment of amebic IgA proteolytic activity in a soluble fraction of amebic sonicate. Degradation of serum IgA by amebic sonicate was completely inhibited by the cysteine proteinase inhibitors trans-epoxysuccinyl-l-Ieucylamino(4-guanidino)butane (E-64, 100 µ,M) and benzyloxycarbonyl-phenyl-alanyl-alanyl-fluoromethyl ketone (Z-Phe-AlaCH2F, 12.5 µM). Secretion of degradative activity, the optimal pH, and the inhibition by E-64 and Z-Phe-Ala-CH2F indicates that cysteine proteinase activity is predominately responsible for the degradation of human IgA by E. histolytica.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/168.5.1319</identifier><identifier>PMID: 8228372</identifier><identifier>CODEN: JIDIAQ</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>Animals ; Biological and medical sciences ; Concise Communications ; Cysteine Endopeptidases - metabolism ; Cysteine Proteinase Inhibitors - pharmacology ; Dipeptides - pharmacology ; Entamoeba histolytica ; Entamoeba histolytica - enzymology ; Entamoeba histolytica - metabolism ; Enzymes ; Epithelial cells ; Fundamental and applied biological sciences. Psychology ; Humans ; Immunoglobulin A - metabolism ; Immunoglobulins ; Infectious diseases ; Ketones - pharmacology ; Leucine - analogs &amp; derivatives ; Leucine - pharmacology ; Life cycle. Host-agent relationship. Pathogenesis ; Mucus ; Parasites ; Particulate matter ; Protease inhibitors ; Protozoa ; Secretion ; Subcellular Fractions - enzymology ; Subcellular Fractions - metabolism ; Trophozoites</subject><ispartof>The Journal of infectious diseases, 1993-11, Vol.168 (5), p.1319-1322</ispartof><rights>Copyright 1993 The University of Chicago</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c482t-e34d52eb9424cf0866556201933a323dbfb5cd82e892b00c10d625655956374e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30113659$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30113659$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27924,27925,58017,58250</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4070200$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8228372$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kelsall, Brian L.</creatorcontrib><creatorcontrib>Ravdin, Jonathan I.</creatorcontrib><title>Degradation of Human IgA by Entamoeba histolytica</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>To determine whether the virulent enteric pathogen Entamoeba histolytica degrades human IgA molecules, serum and secretory IgA was exposed to viable axenic trophozoites (strain HM1:IMSS), a parasite sonicate, and medium conditioned by incubation with live trophozoites. IgA was completely degraded under all conditions, proteinase activity was maximal at a neutral pH, and there was a four- to eightfold enrichment of amebic IgA proteolytic activity in a soluble fraction of amebic sonicate. Degradation of serum IgA by amebic sonicate was completely inhibited by the cysteine proteinase inhibitors trans-epoxysuccinyl-l-Ieucylamino(4-guanidino)butane (E-64, 100 µ,M) and benzyloxycarbonyl-phenyl-alanyl-alanyl-fluoromethyl ketone (Z-Phe-AlaCH2F, 12.5 µM). Secretion of degradative activity, the optimal pH, and the inhibition by E-64 and Z-Phe-Ala-CH2F indicates that cysteine proteinase activity is predominately responsible for the degradation of human IgA by E. histolytica.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Concise Communications</subject><subject>Cysteine Endopeptidases - metabolism</subject><subject>Cysteine Proteinase Inhibitors - pharmacology</subject><subject>Dipeptides - pharmacology</subject><subject>Entamoeba histolytica</subject><subject>Entamoeba histolytica - enzymology</subject><subject>Entamoeba histolytica - metabolism</subject><subject>Enzymes</subject><subject>Epithelial cells</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Immunoglobulin A - metabolism</subject><subject>Immunoglobulins</subject><subject>Infectious diseases</subject><subject>Ketones - pharmacology</subject><subject>Leucine - analogs &amp; derivatives</subject><subject>Leucine - pharmacology</subject><subject>Life cycle. Host-agent relationship. Pathogenesis</subject><subject>Mucus</subject><subject>Parasites</subject><subject>Particulate matter</subject><subject>Protease inhibitors</subject><subject>Protozoa</subject><subject>Secretion</subject><subject>Subcellular Fractions - enzymology</subject><subject>Subcellular Fractions - metabolism</subject><subject>Trophozoites</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkDtPwzAUhS0EKuXxAxiQMiC2tNe-sZ2MqBRagcRSVMRiOY5TAnmAnUr035OopYxMd_jOOVf6CLmgMKKQ4Lio86zwYyriER9RpMkBGVKOMhSC4iEZAjAW0jhJjsmJ9-8AEKGQAzKIGYtRsiGht3bldKbboqmDJg9m60rXwXx1E6SbYFq3umpsqoO3wrdNuWkLo8_IUa5Lb89395Q8300Xk1n4-HQ_n9w8hiaKWRtajDLObJpELDI5xEJwLhjQBFEjwyzNU26ymNk4YSmAoZAJxrtQwgXKyOIpud7ufrrma219q6rCG1uWurbN2ispgCMw_DfY2WGcyz5It0HjGu-dzdWnKyrtNoqC6n2qrc--objqfXady934Oq1stm_sBHb8ase1N7rMna5Nt_Abi0ACA_ibee88uj1GoBQF79-EW955tt97rt2HEhIlV7OXVzVbLieSPixUhD--mJSz</recordid><startdate>19931101</startdate><enddate>19931101</enddate><creator>Kelsall, Brian L.</creator><creator>Ravdin, Jonathan I.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>19931101</creationdate><title>Degradation of Human IgA by Entamoeba histolytica</title><author>Kelsall, Brian L. ; Ravdin, Jonathan I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c482t-e34d52eb9424cf0866556201933a323dbfb5cd82e892b00c10d625655956374e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Concise Communications</topic><topic>Cysteine Endopeptidases - metabolism</topic><topic>Cysteine Proteinase Inhibitors - pharmacology</topic><topic>Dipeptides - pharmacology</topic><topic>Entamoeba histolytica</topic><topic>Entamoeba histolytica - enzymology</topic><topic>Entamoeba histolytica - metabolism</topic><topic>Enzymes</topic><topic>Epithelial cells</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Immunoglobulin A - metabolism</topic><topic>Immunoglobulins</topic><topic>Infectious diseases</topic><topic>Ketones - pharmacology</topic><topic>Leucine - analogs &amp; derivatives</topic><topic>Leucine - pharmacology</topic><topic>Life cycle. Host-agent relationship. Pathogenesis</topic><topic>Mucus</topic><topic>Parasites</topic><topic>Particulate matter</topic><topic>Protease inhibitors</topic><topic>Protozoa</topic><topic>Secretion</topic><topic>Subcellular Fractions - enzymology</topic><topic>Subcellular Fractions - metabolism</topic><topic>Trophozoites</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kelsall, Brian L.</creatorcontrib><creatorcontrib>Ravdin, Jonathan I.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kelsall, Brian L.</au><au>Ravdin, Jonathan I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Degradation of Human IgA by Entamoeba histolytica</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>1993-11-01</date><risdate>1993</risdate><volume>168</volume><issue>5</issue><spage>1319</spage><epage>1322</epage><pages>1319-1322</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><coden>JIDIAQ</coden><abstract>To determine whether the virulent enteric pathogen Entamoeba histolytica degrades human IgA molecules, serum and secretory IgA was exposed to viable axenic trophozoites (strain HM1:IMSS), a parasite sonicate, and medium conditioned by incubation with live trophozoites. IgA was completely degraded under all conditions, proteinase activity was maximal at a neutral pH, and there was a four- to eightfold enrichment of amebic IgA proteolytic activity in a soluble fraction of amebic sonicate. Degradation of serum IgA by amebic sonicate was completely inhibited by the cysteine proteinase inhibitors trans-epoxysuccinyl-l-Ieucylamino(4-guanidino)butane (E-64, 100 µ,M) and benzyloxycarbonyl-phenyl-alanyl-alanyl-fluoromethyl ketone (Z-Phe-AlaCH2F, 12.5 µM). Secretion of degradative activity, the optimal pH, and the inhibition by E-64 and Z-Phe-Ala-CH2F indicates that cysteine proteinase activity is predominately responsible for the degradation of human IgA by E. histolytica.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>8228372</pmid><doi>10.1093/infdis/168.5.1319</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-1899
ispartof The Journal of infectious diseases, 1993-11, Vol.168 (5), p.1319-1322
issn 0022-1899
1537-6613
language eng
recordid cdi_proquest_miscellaneous_76053023
source MEDLINE; JSTOR Archive Collection A-Z Listing
subjects Animals
Biological and medical sciences
Concise Communications
Cysteine Endopeptidases - metabolism
Cysteine Proteinase Inhibitors - pharmacology
Dipeptides - pharmacology
Entamoeba histolytica
Entamoeba histolytica - enzymology
Entamoeba histolytica - metabolism
Enzymes
Epithelial cells
Fundamental and applied biological sciences. Psychology
Humans
Immunoglobulin A - metabolism
Immunoglobulins
Infectious diseases
Ketones - pharmacology
Leucine - analogs & derivatives
Leucine - pharmacology
Life cycle. Host-agent relationship. Pathogenesis
Mucus
Parasites
Particulate matter
Protease inhibitors
Protozoa
Secretion
Subcellular Fractions - enzymology
Subcellular Fractions - metabolism
Trophozoites
title Degradation of Human IgA by Entamoeba histolytica
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T05%3A04%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Degradation%20of%20Human%20IgA%20by%20Entamoeba%20histolytica&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Kelsall,%20Brian%20L.&rft.date=1993-11-01&rft.volume=168&rft.issue=5&rft.spage=1319&rft.epage=1322&rft.pages=1319-1322&rft.issn=0022-1899&rft.eissn=1537-6613&rft.coden=JIDIAQ&rft_id=info:doi/10.1093/infdis/168.5.1319&rft_dat=%3Cjstor_proqu%3E30113659%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16825573&rft_id=info:pmid/8228372&rft_jstor_id=30113659&rfr_iscdi=true